Company Profiles

driven by the PitchBook Platform

Ra Pharmaceuticals

Description

Developer of drugs based on intracellular protein-protein interactions. The company is developing a new class of drugs, cyclomimetics, with the diversity and specificity of antibodies, coupled with the oral bioavailability of small molecules.

2008

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$58.5M

Latest Deal Amount

$85.5M

Total Amount Raised

Description

Developer of drugs based on intracellular protein-protein interactions. The company is developing a new class of drugs, cyclomimetics, with the diversity and specificity of antibodies, coupled with the oral bioavailability of small molecules.

Website:

www.rapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

One Kendall Square Suite B14301 Cambridge, MA 02139United States +1 (617) 401-4060
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ra Pharmaceuticals's full profile, request a free trial.

Ra Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ra Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Ra Pharmaceuticals Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Amgen VenturesCorporate Venture CapitalMinority000 0000000 0000
Lightstone VenturesVenture CapitalMinority000 0000000 0000
Limulus Venture PartnersVenture CapitalMinority000 0000000 0000
MorgenthalerVenture CapitalMinority000 0000000 0000
New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
Amgen Ventures Corporate Venture Capital
Lightstone Ventures Venture Capital
Limulus Venture Partners Venture Capital
Morgenthaler Venture Capital
New Enterprise Associates Venture Capital

Ra Pharmaceuticals Executive Team (8)

NameTitleBoard
Seat
Contact
Info
David LubnerChief Financial Officer & Executive Vice President, Operations
Kristopher Josephson Ph.DDirector, Molecular Biology
Pamela Esposito Ph.DChief Business Officer
Kerry BlackExecutive Director, Operations
Doug Treco Ph.DChief Executive Officer, President, Board Member & Co-Founder
David Lubner Chief Financial Officer & Executive Vice President, Operations
Kristopher Josephson Ph.D Director, Molecular Biology
Pamela Esposito Ph.D Chief Business Officer
Kerry Black Executive Director, Operations
Doug Treco Ph.D Chief Executive Officer, President, Board Member & Co-Founder

Ra Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Doug Treco Ph.DRa PharmaceuticalsChief Executive Officer, President, Board Member & Co-Founder000 0000
Edward MathersNew Enterprise AssociatesBoard Member000 0000
Jason LettmannLightstone VenturesBoard Member000 0000
Lauren Silverman Ph.DNovartis Venture FundsBoard Member000 0000
Markus Goebel Ph.DNovartis Venture FundsBoard Member000 0000
Doug Treco Ph.D Chief Executive Officer, President, Board Member & Co-Founder Ra Pharmaceuticals
Edward Mathers Board Member New Enterprise Associates
Jason Lettmann Board Member Lightstone Ventures
Lauren Silverman Ph.D Board Member Novartis Venture Funds
Markus Goebel Ph.D Board Member Novartis Venture Funds
Request full access to PitchBook